期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

替吉奥联合多西紫杉醇治疗晚期胃癌的临床观察 被引量：1

Clinical Observation of S-1 Combined with Docetaxel in the Treatment of Advanced Gastric Cancer
下载PDF
导出
摘要 目的观察替吉奥联合多西紫杉醇治疗晚期胃癌的临床疗效。方法 40例晚期胃癌患者采用口服替吉奥联合静脉滴注多西紫杉醇方案治疗。结果 40例患者中,PR19例、SD13例、PD8例,总有效率为47.50%,临床受益率为80.00%。主要毒副反应为白细胞减少、血小板减少、恶心呕吐及腹泻。结论替吉奥联合多西紫杉醇治疗晚期胃癌安全有效。 Objective To observe the efficacy of S-1 combined with docetaxel in the treatment of advanced gastric cancer. Methods Forty patients with advanced gastric cancer received S-1 combined with docetaxel. Results Of the 40 patients, PR was observed in the 19 patients, SD in the 13 patients, PD in the 8 patients, the total effective rate was 47.50%, the clinical benefit rate was 80.00%. The main toxicities were leukopenia, thrombocytopenia, nausea and vomiting, diarrhea. Conclusion S-1 combined with docetaxel is effect and safe for the patients with ad- vanced gastric cancer.
作者 王凤庭
机构地区 曲靖市第一人民医院
出处 《肿瘤基础与临床》 2014年第5期387-388,共2页 journal of basic and clinical oncology
关键词 晚期胃癌 替吉奥 多西紫杉醇 advanced gastric cancer S-I docetaxel
分类号 R735.2 [医药卫生—肿瘤] R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1周爱萍,李玉升,杨林,宋岩,孙永琨,张雯,崔成旭,依荷巴丽·迟,袁兴华,吕宁,王金万.多西紫杉醇与替吉奥联合铂类治疗晚期胃癌的Ⅱ期临床观察[J].中华医学杂志,2012,92(24):1677-1680. 被引量：23
  • 2秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量：268
  • 3Koizumi W,Kurihara M, Nakano S,et al. Phase II study of S-l,anovel oral derivative of 5-fluorouracil, in advanced gastric cancer.For the S-l Cooperative Gastric Cancer Study Group[ J]. Oncology,2000,58(3) :191 -197.
  • 4Ueda Y,Yamagishi H,Ichikawa D,et al. Multicenter phase D studyof weekly paclitaxel plus S-l combination chemotherapy in patientswith advanced gastric cancer[ J]. Gastric Cancer,2010,13(3) : 149-154.

二级参考文献27

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量：60
  • 2Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group. J Clin Oncol, 2006, 24:4991-4997.
  • 3Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol, 2009, 10 : 1063-1069.
  • 4Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial) : a phase III trial. Lancet Oncol, 2008, 9:215- 221.
  • 5Sato Y, Takayama T, Sagawa T,et al. Phase II study of S-I, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Cancer Chemother Pharmacol, 2010, 66:721-728.
  • 6Nakayama N, Koizumi W, Sasaki T. Phase I1 study of combination therapy with docetaxel, cisplatin, and S-1 (DCS) for advanced gastric cancer: ( KDOG 0601 ). J Clin Oncol, 2009, 27 : abstr 4555.
  • 7Cunningham D, Allure WH, Stenning SP, et al. Studies on preoperative versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355:11-20.
  • 8Boiege V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil to surgery alone in adenocarcinoma of the stomach and lower esophagus: FNLCC ACCCORD07-FFCD 9703 trial. J Clin Oncol, 2007, 25 : abstr 4510.
  • 9Sym SJ, Chang HM, Ryu MH, et al. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Ann Surg Oncol, 2010, 17:1024-1032.
  • 10Inoue K, Nakane Y, Kogire M, et al. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Eur J Surg Oncol, 2012, 38 : 143-149.

共引文献289

同被引文献10

  • 1Wang M,Wu M,Wang W,Wang Q,Wang Y.Docetexal plus S-1 versus oxaliplatin plus S-1 for firstline treatment of patients with advanced gastric cancer:a retrospective study. Oncol Res Treat . 2014
  • 2Eiji Oki,Yasunori Emi,Tetsuya Kusumoto,Yoshihisa Sakaguchi,Manabu Yamamoto,Noriaki Sadanaga,Mototsugu Shimokawa,Takeharu Yamanaka,Hiroshi Saeki,Masaru Morita,Ikuo Takahashi,Naoki Hirabayashi,Kenji Sakai,Hiroyuki Orita,Shinichi Aishima,Yoshihiro Kakeji,Kazuya Yamaguchi,Kazuhiro Yoshida,Hideo Baba,Yoshihiko Maehara.Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer[J]. Annals of Surgical Oncology . 2014 (7)
  • 3Wasaburo Koizumi,Yeul Hong Kim,Masashi Fujii,Hoon Kyo Kim,Hiroshi Imamura,Kyung Hee Lee,Takuo Hara,Hyun Cheol Chung,Taroh Satoh,Jae Yong Cho,Hisashi Hosaka,Akihito Tsuji,Akinori Takagane,Mikito Inokuchi,Kazuaki Tanabe,Tatsuya Okuno,Mariko Ogura,Kazuhiro Yoshida,Masahiro Takeuchi,Toshifusa Nakajima.Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)[J]. Journal of Cancer Research and Clinical Oncology . 2014 (2)
  • 4Takashi Kosaka,Hirotoshi Akiyama,Hirochika Makino,Ryo Takagawa,Jun Kimura,Hidetaka Ono,Chikara Kunisaki,Itaru Endo.Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer[J]. Cancer Chemotherapy and Pharmacology . 2014 (2)
  • 5Ulrich Ronellenfitsch,Matthias Schwarzbach,Ralf Hofheinz,Peter Kienle,Meinhard Kieser,Tracy E. Slanger,Bryan Burmeister,David Kelsen,Donna Niedzwiecki,Christoph Schuhmacher,Susan Urba,Cornelis van de Velde,Thomas N. Walsh,Marc Ychou,Katrin Jensen.Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data[J]. European Journal of Cancer . 2013
  • 6Ychou Marc,Boige Valérie,Pignon Jean-Pierre,Conroy Thierry,Bouché Olivier,Lebreton Gilles,Ducourtieux Muriel,Bedenne Laurent,Fabre Jean-Michel,Saint-Aubert Bernard,Genève Jean,Lasser Philippe,Rougier Philippe.Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2011
  • 7Ott Katja,Lordick Florian,Blank Susanne,Büchler Markus.Gastric cancer: surgery in 2011. Langenbeck’s archives of surgery / Deutsche Gesellschaft für Chirurgie . 2011
  • 8Ajani Jaffer A,Faust Josephine,Ikeda Kazumasa,Yao James C,Anbe Hiroshi,Carr Kelli L,Houghton Michele,Urrea Peter.Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2005
  • 9Cunningham D,Allum WH,Stenning SP,et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Homeopathy . 2006
  • 10Christoph Schuhmacher,Stephan Gretschel,Florian Lordick.Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954. Journal of Clinical Oncology . 2010

引证文献1

二级引证文献2

肿瘤基础与临床
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部